Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
2138072 | Leukemia Research | 2011 | 7 Pages |
Abstract
Acute promyelocytic leukemia (APL) is a model system of aberrant transcription in cancer. We sought to elucidate the mechanism of action of the variant fusion NuMA-RARα in APL, using the hCG-NuMA-RARα transgenic model. We report that subcellular localization of NuMA-RARα in transgenic mice is dependent upon its protein expression and transgene dosage. Subcellular localization of the fusion is inversely correlated with extent of gene deregulation at the mRNA level for Cebpα, CebpÉ and Pu.1. Finally, we report that phenotype onset is correlated with NuMA-RARα copy number; mice with higher copy number developing disease later than those with lower copy number.
Keywords
Related Topics
Life Sciences
Biochemistry, Genetics and Molecular Biology
Cancer Research
Authors
Mahadeo A. Sukhai, Mariam Thomas, Soheila A. Hamadanizadeh, Yali Xuan, Richard A. Wells, Suzanne Kamel-Reid,